CVS Health Statistics
Total Valuation
CVS Health has a market cap or net worth of CAD 122.84 billion. The enterprise value is 226.03 billion.
Market Cap | 122.84B |
Enterprise Value | 226.03B |
Important Dates
The next estimated earnings date is Thursday, May 1, 2025.
Earnings Date | May 1, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | -2.17% |
Shares Change (QoQ) | +0.16% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 1.26B |
Valuation Ratios
The trailing PE ratio is 18.50.
PE Ratio | 18.50 |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.10, with an EV/FCF ratio of 24.83.
EV / Earnings | 34.05 |
EV / Sales | 0.43 |
EV / EBITDA | 10.10 |
EV / EBIT | 19.69 |
EV / FCF | 24.83 |
Financial Position
The company has a current ratio of 0.81, with a Debt / Equity ratio of 1.09.
Current Ratio | 0.81 |
Quick Ratio | 0.56 |
Debt / Equity | 1.09 |
Debt / EBITDA | 5.30 |
Debt / FCF | 13.11 |
Interest Coverage | 2.71 |
Financial Efficiency
Return on equity (ROE) is 6.02% and return on invested capital (ROIC) is 3.19%.
Return on Equity (ROE) | 6.02% |
Return on Assets (ROA) | 1.99% |
Return on Invested Capital (ROIC) | 3.19% |
Return on Capital Employed (ROCE) | 4.76% |
Revenue Per Employee | 2.06M |
Profits Per Employee | 25,583 |
Employee Count | 300,000 |
Asset Turnover | 1.47 |
Inventory Turnover | 17.79 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -17.17% in the last 52 weeks. The beta is 0.53, so CVS Health's price volatility has been lower than the market average.
Beta (5Y) | 0.53 |
52-Week Price Change | -17.17% |
50-Day Moving Average | 15.55 |
200-Day Moving Average | 14.51 |
Relative Strength Index (RSI) | 61.67 |
Average Volume (20 Days) | 7,615 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 1.81 |
Income Statement
In the last 12 months, CVS Health had revenue of CAD 533.31 billion and earned 6.64 billion in profits. Earnings per share was 5.27.
Revenue | 533.31B |
Gross Profit | 70.86B |
Operating Income | 11.54B |
Pretax Income | 8.85B |
Net Income | 6.64B |
EBITDA | 18.15B |
EBIT | 11.54B |
Earnings Per Share (EPS) | 5.27 |
Balance Sheet
The company has 15.82 billion in cash and 119.31 billion in debt, giving a net cash position of -103.49 billion.
Cash & Cash Equivalents | 15.82B |
Total Debt | 119.31B |
Net Cash | -103.49B |
Net Cash Per Share | n/a |
Equity (Book Value) | 108.96B |
Book Value Per Share | 86.28 |
Working Capital | -22.97B |
Cash Flow
In the last 12 months, operating cash flow was 13.10 billion and capital expenditures -4.00 billion, giving a free cash flow of 9.10 billion.
Operating Cash Flow | 13.10B |
Capital Expenditures | -4.00B |
Free Cash Flow | 9.10B |
FCF Per Share | n/a |
Margins
Gross margin is 13.29%, with operating and profit margins of 2.16% and 1.24%.
Gross Margin | 13.29% |
Operating Margin | 2.16% |
Pretax Margin | 1.66% |
Profit Margin | 1.24% |
EBITDA Margin | 3.40% |
EBIT Margin | 2.16% |
FCF Margin | 1.71% |
Dividends & Yields
CVS Health does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | 73.10% |
Buyback Yield | 2.17% |
Shareholder Yield | 2.17% |
Earnings Yield | 5.40% |
FCF Yield | 7.41% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
CVS Health has an Altman Z-Score of 2.11. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.11 |
Piotroski F-Score | n/a |